Thomas Nyström
#183,189
Most Influential Person Now
Researcher ORCID 0000-0002-3462-7990
Thomas Nyström's AcademicInfluence.com Rankings
Thomas Nyströmcomputer-science Degrees
Computer Science
#11686
World Rank
#12413
Historical Rank
Machine Learning
#5372
World Rank
#5442
Historical Rank
Artificial Intelligence
#5791
World Rank
#5878
Historical Rank
Database
#8757
World Rank
#9194
Historical Rank
Download Badge
Computer Science
Why Is Thomas Nyström Influential?
(Suggest an Edit or Addition)Thomas Nyström's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. (2004) (641)
- Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial (2017) (438)
- Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice (2010) (336)
- Endothelial inflammation in insulin resistance (2005) (283)
- Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis. (2017) (282)
- Inflammation and the etiology of type 2 diabetes (2006) (230)
- Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor (2010) (199)
- Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism (2005) (183)
- The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain (2013) (137)
- Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock (2007) (131)
- Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study (2017) (116)
- Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy (2011) (116)
- Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety (2012) (100)
- Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013 (2016) (97)
- Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality. (2016) (81)
- Inorganic nitrite stimulates pancreatic islet blood flow and insulin secretion. (2012) (79)
- Dietary nitrate reduces resting metabolic rate: a randomized, crossover study in humans. (2014) (78)
- Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization (2014) (78)
- Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes (2017) (76)
- A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3) (2018) (76)
- Dapagliflozin Compared to DPP-4 inhibitors is Associated with Lower Risk of Cardiovascular Events and All-cause Mortality in Type 2 Diabetes Patients (CVD-REAL Nordic): a multinational observational study. (2017) (71)
- The potential beneficial role of glucagon-like peptide-1 in endothelial dysfunction and heart failure associated with insulin resistance. (2008) (69)
- Exendin-4 protects endothelial cells from lipoapoptosis by PKA, PI3K, eNOS, p38 MAPK, and JNK pathways. (2013) (63)
- Long-term prognosis in patients with type 1 and 2 diabetes mellitus after coronary artery bypass grafting. (2015) (57)
- Hypoglycemic pharmacological treatment of type 2 diabetes: Targeting the endothelium (2009) (54)
- Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study (2019) (54)
- Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease. (2004) (51)
- Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo (2009) (50)
- Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes (2012) (48)
- Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia. (2017) (45)
- Increased levels of tumour necrosis factor-α (TNF-α) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction (2006) (45)
- Antidiabetic agents and endothelial dysfunction - beyond glucose control. (2015) (41)
- The potent vasodilator ethyl nitrite is formed upon reaction of nitrite and ethanol under gastric conditions. (2008) (41)
- The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway (2018) (40)
- Gliptin‐mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon‐like peptide‐1 receptor (2016) (38)
- Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes (2018) (37)
- Persistent endothelial dysfunction is related to elevated C-reactive protein (CRP) levels in Type II diabetic patients after acute myocardial infarction. (2005) (37)
- Glycemic Control in Type 1 Diabetes and Long-Term Risk of Cardiovascular Events or Death After Coronary Artery Bypass Grafting. (2015) (35)
- A simple intravenous glucose tolerance test for assessment of insulin sensitivity (2011) (35)
- Effects of high-fat diet and the anti-diabetic drug metformin on circulating GLP-1 and the relative number of intestinal L-cells (2014) (35)
- Glucagon-Like Receptor 1 Agonists and DPP-4 Inhibitors: Potential Therapies for the Treatment of Stroke (2015) (34)
- Relationship between preoperative hemoglobin A1c levels and long-term mortality after coronary artery bypass grafting in patients with type 2 diabetes mellitus. (2016) (33)
- Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis (2014) (33)
- Insulin sensitivity and beta-cell function after carbohydrate oral loading in hip replacement surgery: a double-blind, randomised controlled clinical trial. (2014) (33)
- Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy (2015) (33)
- Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin (2018) (32)
- Glucagon-like receptor 1 agonists and DPP-4 inhibitors: Anti-diabetic drugs with anti-stroke potential (2017) (30)
- Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. (2006) (30)
- C-reactive protein: a marker or a player? (2007) (29)
- Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart disease (2010) (26)
- Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10 (2018) (26)
- Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4 (2016) (25)
- 40th EASD Annual Meeting of the European Association for the Study of Diabetes (2004) (25)
- Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study (2014) (25)
- Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study (2020) (22)
- Glucagon-Like Peptide-1 Receptor Activation Does Not Affect Re-Endothelialization but Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Nondiabetic Model of Arterial Injury (2015) (22)
- Effects of some anti-diabetic and cardioprotective agents on proliferation and apoptosis of human coronary artery endothelial cells (2012) (22)
- Plasma levels of glucagon like peptide‐1 associate with diastolic function in elderly men (2010) (22)
- PCI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease. (2017) (21)
- Different patterns of second‐line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study (2018) (21)
- Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4 (2016) (21)
- Cardiorespiratory fitness predicts insulin action and secretion in healthy individuals. (2012) (20)
- Evidence for paracrine/autocrine regulation of GLP-1-producing cells. (2013) (20)
- Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice (2014) (20)
- GLP-1R activation for the treatment of stroke: Updating and future perspectives (2014) (20)
- Obesity-induced type 2 diabetes impairs neurological recovery after stroke in correlation with decreased neurogenesis and persistent atrophy of parvalbumin-positive interneurons. (2019) (17)
- Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry (2020) (16)
- Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure (2016) (15)
- Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and Stroke (2019) (15)
- Exendin-4 restores glucolipotoxicity-induced gene expression in human coronary artery endothelial cells. (2012) (15)
- Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting (2017) (14)
- Sex, Diastolic Blood Pressure, and Outcome after Thrombolysis for Ischemic Stroke (2014) (14)
- Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014 (2017) (14)
- Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme (2016) (14)
- Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes (2019) (13)
- Bezafibrate‐induced improvement in glucose uptake and endothelial function in protease inhibitor‐associated insulin resistance (2002) (13)
- Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study (2021) (13)
- Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study (2021) (13)
- Regulation of Glycemia in the Recovery Phase After Stroke Counteracts the Detrimental Effect of Obesity-Induced Type 2 Diabetes on Neurological Recovery (2020) (13)
- Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study (2017) (13)
- Dipeptidyl peptidase-4 inhibitors and sulfonylureas prevent the progressive impairment of the nigrostriatal dopaminergic system induced by diabetes during aging (2020) (11)
- Type 2 diabetes alters hippocampal gamma oscillations: A potential mechanism behind impaired cognition (2017) (11)
- Accuracy and precision of commonly used methods for quantifying surgery-induced insulin resistance: Prospective observational study (2014) (10)
- Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide observational study (2019) (9)
- Role of Prolactin Receptors in Lymphangioleiomyomatosis (2016) (9)
- Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu (2016) (8)
- Intravenous hydration with a 2.5% glucose solution in Type II diabetes. (2006) (8)
- Normalisation of glucose metabolism by exendin‐4 in the chronic phase after stroke promotes functional recovery in male diabetic mice (2021) (7)
- Western Diet Accelerates the Impairment of Odor-Related Learning and Olfactory Memory in the Mouse (2020) (7)
- Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel‐group study (2019) (7)
- Suppressor of cytokine signaling 2 (SOCS2) deletion protects against multiple low dose streptozotocin-induced type 1 diabetes in adult male mice (2016) (7)
- Plasma Volume Expansion Resulting from Intravenous Glucose Tolerance Test (2011) (7)
- Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride (2021) (7)
- Long‐Term Risk of Stroke in Patients With Type 1 and Type 2 Diabetes Following Coronary Artery Bypass Grafting (2015) (6)
- The Stroke-Induced Increase of Somatostatin-Expressing Neurons is Inhibited by Diabetes: A Potential Mechanism at the Basis of Impaired Stroke Recovery (2020) (6)
- Glycerol kinase deficiency in adult hypoglycemic acidemia. (2011) (6)
- The impact of transcutaneous oxygen pressure measurement in patients with suspected critical lower limb ischemia. (2016) (6)
- Diabetes downregulates the antimicrobial peptide psoriasin and increases E. coli burden in the urinary bladder (2022) (4)
- Glycated Hemoglobin A1c Levels in Type 1 Diabetes Mellitus and Outcomes After Myocardial Infarction. (2019) (4)
- Second-line treatment with sulfonylurea compared to DPP4 inhibitors demonstrated associations with earlier treatment intensification with insulin (2015) (4)
- Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes: A Predefined Subgroup Analysis From the DETO2X-AMI Trial (2019) (4)
- Gliptins-mediated neuroprotection against stroke requires chronic pre-treatment and is glucagon-like peptide-1 receptor independent: Gliptins for the treatment of stroke (2016) (4)
- LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study (2020) (4)
- Dapagliflozin Is Associated With Lower Risk Of Hospitalization For Kidney Disease, Heart Failure And All Cause Death Compared To DPP-4i: CVD-REAL Nordic (2017) (4)
- Acute regulation of pancreatic islet microcirculation and glycaemia by telmisartan and ramipril: discordant effects between normal and type 2 diabetic rats. (2013) (4)
- Effects on repetitive 24-hour ambulatory blood pressure in subjects with type II diabetes randomized to liraglutide or glimepiride treatment both in combination with metformin: a randomized open parallel-group study. (2018) (4)
- Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes (2020) (3)
- Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study. (2021) (3)
- Development of type 2 diabetes and insulin resistance in people with HIV infection: Prevalence, incidence and associated factors (2021) (3)
- Plasma volume expansion from the intravenous glucose tolerance test before and after hip replacement surgery (2013) (3)
- Earlier intensified insulin treatment of Type 1 diabetes and its association with long‐term macrovascular and renal complications (2016) (2)
- [Chronic inflammation can cause type 2 diabetes]. (2004) (2)
- Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms (2020) (2)
- Admission glucose as a prognostic marker for all-cause mortality and cardiovascular disease (2022) (2)
- Dapagliflozin is Associated With Lower Risk of Hospitalization for Heart Failure, Major Adverse Cardiovascular Events and All-Cause Death Compared to DPP-4i in T2D Patients: CVD-REAL Nordic (2017) (2)
- Circadian cortisol and GH profiles in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy (2014) (2)
- 127-LB: Effectiveness and Safety of Empagliflozin in Routine Care in Europe and East Asia: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study (2021) (2)
- Diet-induced weight loss in obese/diabetic mice normalizes glucose metabolism and promotes functional recovery after stroke (2021) (2)
- Reduced expression of OXPHOS and DNA damage genes is linked to protection from microvascular complications in long-term type 1 diabetes: the PROLONG study (2021) (2)
- Risk factors for nephropathy in persons with type 1 diabetes: a population-based study (2022) (1)
- The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5) (2020) (1)
- Plasma volume expansion from the intravenous glucose tolerance test before and after hip replacement surgery (2013) (1)
- 88Oxygen therapy in myocardial infarction patients with or without diabetes mellitus - A predefined subgroup analysis from the DETO2X-AMI trial (2019) (1)
- Patient characteristics, treatment and prevalence/incidence of the type 2 diabetes population in Sweden : a nationwide study from 2006 to 2013 (2015) (1)
- The neuroprotective efficacy of the DPP-4 inhibitor linagliptin against stroke is not mediated by GLP-1 receptor activation (2015) (1)
- 232-LB: Cardiovascular Complications in T1D and T2D Patients Show More Similarities than Differences (2019) (1)
- Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study (2018) (1)
- First-line and intensified treatment with glucose lowering drugs in the Swedish type 2 diabetes population (2015) (1)
- Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8). (2022) (0)
- A High-Fat Diet Increases Activation of The Glucagon-Like Peptide-1-Producing Neurons in The Nucleus Tractus Solitarii; An Effect That is Partially Reversed By Drugs Normalizing Glycaemia (2021) (0)
- Therapeutical Role of Dietary Inorganic Nitrate in eNOSdeficient mice with Metabolic Syndrome (2010) (0)
- Author response for "Majority of people with type 1 diabetes and multiple daily insulin injection benefit by using Continuous Glucose Monitoring: An analysis based on the GOLD randomised trial ( GOLD ‐5)" (2020) (0)
- Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study. (2023) (0)
- History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case–control study (2023) (0)
- Review for "Double diabetes: A distinct high‐risk group?" (2019) (0)
- Second-line treatment with sulfonylurea compared to DPP4 inhibitors is associated with risk of cardiovascular disease, all-cause mortality and severe hypoglycaemia (2015) (0)
- Abstract 11776: Preoperative Disturbances of Glucose Metabolism and Mortality After Coronary Artery Bypass Grafting (2019) (0)
- Correction: Admission glucose as a prognostic marker for all-cause mortality and cardiovascular disease (2022) (0)
- Author response for "Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study" (2019) (0)
- Normalization of glucose metabolism by Exendin-4 in the chronic phase after stroke promotes functional recovery in diabetes (2021) (0)
- Reply: Association of Glycemic Control in Type 1 Diabetes With Long-Term Risk After CABG. (2015) (0)
- [Glycerol kinase deficiency with debut of symptoms in adult age. Unusual cause of coma, metabolic acidosis, hypoglycemia and hypothermia]. (2010) (0)
- P6400Risk for heart failure after acute myocardial infarction, a nationwide report on 73 303 patients with and without diabetes 2012–2017 in the SWEDEHEART-SCAAR registry (2019) (0)
- Empagliflozin reduces cardiorenal events, healthcare resource use and mortality in Sweden compared to dipeptidyl peptidase‐4 inhibitors: Real world evidence from the Nordic EMPRISE study (2022) (0)
- Insulin sensitivity in patients with Addison's disease: a randomised cross-over trial comparing conventional glucocorticoid replacement therapy with continuous subcutaneous hydrocortisone infusion therapy. (2013) (0)
- Abstract 515: Effects of the Glucagon-Like Peptide-1 Analog Exendin-4 on Reendothelialization and Intimal Hyperplasia Formation in an Animal Model of Vascular Injury (2014) (0)
- Abstract 17182: Long-term Prognosis in Patients with Type 1 and Type 2 Diabetes Mellitus after Coronary Artery Bypass Grafting (2014) (0)
- DPP-4 Inhibitor and Sulfonylurea Differentially Reverse Type 2 Diabetes–Induced Blood–Brain Barrier Leakage and Normalize Capillary Pericyte Coverage (2022) (0)
- Author response for "Risk of first stroke in patients with type 2 diabetes and the relation to glycaemic control: a nationwide observational study" (2019) (0)
- A High-Fat Diet Increases Activation of the Glucagon-Like Peptide-1-Producing Neurons in the Nucleus Tractus Solitarii: an Effect that is Partially Reversed by Drugs Normalizing Glycemia (2021) (0)
- Abstract 476: Glucagon Like Peptide -1 Receptor Activation Does Not Affect Re-endothelialization But Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Non-diabetic Model of Arterial Injury (2015) (0)
- Increased levels of insulin-degrading enzyme in patients with type 2 diabetes mellitus (2022) (0)
- On endothelial function in type 2 diabetic patients with coronary artery disease (2005) (0)
- The Effect of Gliptins to Improve Functional Outcome after Stroke in Mice Is Mediated by the CXCR4/SDF-1α Pathway (2018) (0)
- The Stroke-Induced Increase of Somatostatin-Expressing Neurons is Inhibited by Diabetes: A Potential Mechanism at the Basis of Impaired Stroke Recovery (2020) (0)
- Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention: a Swedish nationwide propensity score matched cohort study (2021) (0)
- Reduced oxidative phosphorylation can be protective against complications in patients with long-standing type 1 diabetes (2019) (0)
- SGLT2i vs bolus insulin as add-on to stable basal insulin treatment in type 2 diabetes and risk of cardiovascular disease and mortality : a nationwide observational study (2018) (0)
- Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational study (2023) (0)
- IDF2022-0622 Mortality and cardiorenal disease in type 1 and type 2 diabetes after COVID-19 and influenza hospitalization in Sweden (2023) (0)
- Effect of Adding Losartan to Standard of Care Treatment on the Risk of Death and Icu Admission Among Hospitalized COVID-19 Patients: A Randomized Trial (2022) (0)
- Dapagliflozin compared to DPP4i treatment is associated with lower risk of kidney disease, heart failure and all-cause death : CVD-REAL Nordic (2017) (0)
- Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data (2022) (0)
- Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin (2018) (0)
- A High-Fat Diet Increases Activation of the Glucagon-Like Peptide-1-Producing Neurons in the Nucleus Tractus Solitarii: an Effect that is Partially Reversed by Drugs Normalizing Glycemia (2021) (0)
- The Pre-Stroke Induction and Normalization of Insulin Resistance Respectively Worsens and Improves Functional Recovery (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas Nyström?
Thomas Nyström is affiliated with the following schools:
